ScholarLens Back to search
1996•Journal of Pharmacology and Experimental TherapeuticsRequires access

The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

Cristina Zocchi, E. Ongini, Andrea Conti, Angela Monopoli, A. Negretti, P. G. BARALDI, Silvio Dionisotti

Open publisher page 197 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 197 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Adenosine, Xanthine, CGS-21680, Adenosine receptor, Adenosine A2A receptor, Chemistry, Pharmacology, Agonist

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. — Research Paper | ScholarLens